MetaVia Inc (MTVA)

1.60 -0.16 (-9.09%) USD  |  NASDAQ  |  Dec 20, 16:00
1.68 +0.08 (+5.00%) After-Hours: 20:00
More

MetaVia Enterprise Value: -7.883M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for MTVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Dermata Therapeutics Inc -3.919M
Cognition Therapeutics Inc 4.168M
ZyVersa Therapeutics Inc 2.550M
Cytokinetics Inc 5.422B
Ocugen Inc 189.76M

Enterprise Value Related Metrics

Net Income (Quarterly) -5.652M
Total Expenses (Quarterly) 6.259M
EPS Diluted (Quarterly) -0.55
Earnings Yield -298.1%